China Pharma Innovation Hinges On Participation Of Medical Experts – SFDA Drug Registration Director
This article was originally published in PharmAsia News
Executive Summary
China approves less than 10 new chemical entities annually, according to SFDA Director of Drug Registration Wei Zhang, who has urged healthcare professionals to join China’s innovation efforts.